TRADING HALTED

Bausch Health Companies Inc VRX:Swiss Exchange

*Data is delayed | CHF
Last | 06/05/19 CET
21.44UNCH (UNCH)
52 week range
21.44 - 21.67

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close24.11
  • 52 Week High21.67
  • 52 Week High Date06/05/19
  • 52 Week Low21.44
  • 52 Week Low Date06/05/19
  • Market Cap11,270.58M
  • Shares Out355.42M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-1.40
  • P/E (TTM)-15.31
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Bausch Health Companies Inc News

There is no recent news for this security.

Latest VRX News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other...
Joseph Papa
Chairman
Paul Herendeen
Chief Financial Officer
Christina Ackermann
Executive Vice President
Address
2150 Saint-Elzear Blvd W
Laval, QC
H7L 4A8
Canada